HAVCR2 and central nervous system cancer: Despite active caspase-1 upregulation (Figure 5A,B), there were no significant differences in IL-1β secretion in response to Tim-3 or Gal-9 knockdown in any of the glioma cell lines (Supplementary Figure S11A,B).